Compared to patients with low CFH concentrations, patients with moderate concentrations had a two and a half-fold increased risk of AKI (odds ratio [OR] moderate vs. low, 2.53 [95% CI, 1.44–4.53], P < 0.001). The gene discussed is CFH; the disease is acute kidney injury.